カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の経口型タダラフィル市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Tadalafil Oral Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19652）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19652
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：102
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の経口型タダラフィル市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

経口型タダラフィル市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経口型タダラフィルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経口型タダラフィル市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・2.5mg錠、5mg錠、10mg錠、20mg錠

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界の経口型タダラフィル市場の主要な市場プレーヤーは以下のとおりです。
・Eli Lilly、Teva、Aurobindo、Sun Pharma、Alembic Pharmaceuticals、Mylan、Accord Healthcare、Cipla、Ajanta Pharma Ltd.、Dr. Reddys Laboratories、Qilu Pharmaceutical、Lupin

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経口型タダラフィル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経口型タダラフィルメーカーの企業概要、2019年～2022年までの経口型タダラフィルの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経口型タダラフィルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経口型タダラフィルの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経口型タダラフィルの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経口型タダラフィル市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経口型タダラフィルの産業チェーンを掲載しています。
・第13、14、15章では、経口型タダラフィルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 経口型タダラフィルの概要
- 種類別分析（2017年vs2021年vs2028年）：2.5mg錠、5mg錠、10mg錠、20mg錠
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界の経口型タダラフィル市場規模・予測
- 世界の経口型タダラフィル生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Eli Lilly、Teva、Aurobindo、Sun Pharma、Alembic Pharmaceuticals、Mylan、Accord Healthcare、Cipla、Ajanta Pharma Ltd.、Dr. Reddys Laboratories、Qilu Pharmaceutical、Lupin
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：2.5mg錠、5mg錠、10mg錠、20mg錠
・用途別分析2017年-2028年：病院、ドラッグストア
・経口型タダラフィルの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・経口型タダラフィルのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・経口型タダラフィルのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・経口型タダラフィルの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・経口型タダラフィルの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Tadalafil Oral market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tadalafil Oral market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Tadalafil Oral global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 2.5 mg tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tadalafil Oral include Eli Lilly, Teva, Aurobindo, Sun Pharma, and Alembic Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tadalafil Oral market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
2.5 mg tablets
5 mg tablets
10mg tablets
20 mg tablets
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Tadalafil Oral market are listed below:
Eli Lilly
Teva
Aurobindo
Sun Pharma
Alembic Pharmaceuticals
Mylan
Accord Healthcare
Cipla
Ajanta Pharma Ltd.
Dr. Reddys Laboratories
Qilu Pharmaceutical
Lupin
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tadalafil Oral product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tadalafil Oral, with price, sales, revenue and global market share of Tadalafil Oral from 2019 to 2022.
Chapter 3, the Tadalafil Oral competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tadalafil Oral breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tadalafil Oral market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tadalafil Oral.
Chapter 13, 14, and 15, to describe Tadalafil Oral sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Tadalafil Oral Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tadalafil Oral Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 2.5 mg tablets
1.2.3 5 mg tablets
1.2.4 10mg tablets
1.2.5 20 mg tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Tadalafil Oral Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Tadalafil Oral Market Size & Forecast
1.4.1 Global Tadalafil Oral Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tadalafil Oral Sales in Volume (2017-2028)
1.4.3 Global Tadalafil Oral Price (2017-2028)
1.5 Global Tadalafil Oral Production Capacity Analysis
1.5.1 Global Tadalafil Oral Total Production Capacity (2017-2028)
1.5.2 Global Tadalafil Oral Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tadalafil Oral Market Drivers
1.6.2 Tadalafil Oral Market Restraints
1.6.3 Tadalafil Oral Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Tadalafil Oral Product and Services
2.1.4 Eli Lilly Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Tadalafil Oral Product and Services
2.2.4 Teva Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Aurobindo
2.3.1 Aurobindo Details
2.3.2 Aurobindo Major Business
2.3.3 Aurobindo Tadalafil Oral Product and Services
2.3.4 Aurobindo Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharma
2.4.1 Sun Pharma Details
2.4.2 Sun Pharma Major Business
2.4.3 Sun Pharma Tadalafil Oral Product and Services
2.4.4 Sun Pharma Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Alembic Pharmaceuticals
2.5.1 Alembic Pharmaceuticals Details
2.5.2 Alembic Pharmaceuticals Major Business
2.5.3 Alembic Pharmaceuticals Tadalafil Oral Product and Services
2.5.4 Alembic Pharmaceuticals Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Tadalafil Oral Product and Services
2.6.4 Mylan Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Tadalafil Oral Product and Services
2.7.4 Accord Healthcare Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cipla
2.8.1 Cipla Details
2.8.2 Cipla Major Business
2.8.3 Cipla Tadalafil Oral Product and Services
2.8.4 Cipla Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ajanta Pharma Ltd.
2.9.1 Ajanta Pharma Ltd. Details
2.9.2 Ajanta Pharma Ltd. Major Business
2.9.3 Ajanta Pharma Ltd. Tadalafil Oral Product and Services
2.9.4 Ajanta Pharma Ltd. Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Dr. Reddys Laboratories
2.10.1 Dr. Reddys Laboratories Details
2.10.2 Dr. Reddys Laboratories Major Business
2.10.3 Dr. Reddys Laboratories Tadalafil Oral Product and Services
2.10.4 Dr. Reddys Laboratories Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Qilu Pharmaceutical
2.11.1 Qilu Pharmaceutical Details
2.11.2 Qilu Pharmaceutical Major Business
2.11.3 Qilu Pharmaceutical Tadalafil Oral Product and Services
2.11.4 Qilu Pharmaceutical Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Lupin
2.12.1 Lupin Details
2.12.2 Lupin Major Business
2.12.3 Lupin Tadalafil Oral Product and Services
2.12.4 Lupin Tadalafil Oral Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tadalafil Oral Breakdown Data by Manufacturer
3.1 Global Tadalafil Oral Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tadalafil Oral Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tadalafil Oral
3.4 Market Concentration Rate
3.4.1 Top 3 Tadalafil Oral Manufacturer Market Share in 2021
3.4.2 Top 6 Tadalafil Oral Manufacturer Market Share in 2021
3.5 Global Tadalafil Oral Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tadalafil Oral Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tadalafil Oral Market Size by Region
4.1.1 Global Tadalafil Oral Sales in Volume by Region (2017-2028)
4.1.2 Global Tadalafil Oral Revenue by Region (2017-2028)
4.2 North America Tadalafil Oral Revenue (2017-2028)
4.3 Europe Tadalafil Oral Revenue (2017-2028)
4.4 Asia-Pacific Tadalafil Oral Revenue (2017-2028)
4.5 South America Tadalafil Oral Revenue (2017-2028)
4.6 Middle East and Africa Tadalafil Oral Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tadalafil Oral Sales in Volume by Type (2017-2028)
5.2 Global Tadalafil Oral Revenue by Type (2017-2028)
5.3 Global Tadalafil Oral Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tadalafil Oral Sales in Volume by Application (2017-2028)
6.2 Global Tadalafil Oral Revenue by Application (2017-2028)
6.3 Global Tadalafil Oral Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tadalafil Oral Sales by Type (2017-2028)
7.2 North America Tadalafil Oral Sales by Application (2017-2028)
7.3 North America Tadalafil Oral Market Size by Country
7.3.1 North America Tadalafil Oral Sales in Volume by Country (2017-2028)
7.3.2 North America Tadalafil Oral Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tadalafil Oral Sales by Type (2017-2028)
8.2 Europe Tadalafil Oral Sales by Application (2017-2028)
8.3 Europe Tadalafil Oral Market Size by Country
8.3.1 Europe Tadalafil Oral Sales in Volume by Country (2017-2028)
8.3.2 Europe Tadalafil Oral Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tadalafil Oral Sales by Type (2017-2028)
9.2 Asia-Pacific Tadalafil Oral Sales by Application (2017-2028)
9.3 Asia-Pacific Tadalafil Oral Market Size by Region
9.3.1 Asia-Pacific Tadalafil Oral Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tadalafil Oral Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tadalafil Oral Sales by Type (2017-2028)
10.2 South America Tadalafil Oral Sales by Application (2017-2028)
10.3 South America Tadalafil Oral Market Size by Country
10.3.1 South America Tadalafil Oral Sales in Volume by Country (2017-2028)
10.3.2 South America Tadalafil Oral Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tadalafil Oral Sales by Type (2017-2028)
11.2 Middle East & Africa Tadalafil Oral Sales by Application (2017-2028)
11.3 Middle East & Africa Tadalafil Oral Market Size by Country
11.3.1 Middle East & Africa Tadalafil Oral Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tadalafil Oral Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tadalafil Oral and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tadalafil Oral
12.3 Tadalafil Oral Production Process
12.4 Tadalafil Oral Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tadalafil Oral Typical Distributors
13.3 Tadalafil Oral Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Tadalafil Oral Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Tadalafil Oral Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly Major Business
Table 5. Eli Lilly Tadalafil Oral Product and Services
Table 6. Eli Lilly Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Tadalafil Oral Product and Services
Table 10. Teva Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 12. Aurobindo Major Business
Table 13. Aurobindo Tadalafil Oral Product and Services
Table 14. Aurobindo Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Sun Pharma Major Business
Table 17. Sun Pharma Tadalafil Oral Product and Services
Table 18. Sun Pharma Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Alembic Pharmaceuticals Major Business
Table 21. Alembic Pharmaceuticals Tadalafil Oral Product and Services
Table 22. Alembic Pharmaceuticals Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mylan Basic Information, Manufacturing Base and Competitors
Table 24. Mylan Major Business
Table 25. Mylan Tadalafil Oral Product and Services
Table 26. Mylan Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Accord Healthcare Major Business
Table 29. Accord Healthcare Tadalafil Oral Product and Services
Table 30. Accord Healthcare Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Cipla Basic Information, Manufacturing Base and Competitors
Table 32. Cipla Major Business
Table 33. Cipla Tadalafil Oral Product and Services
Table 34. Cipla Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Ajanta Pharma Ltd. Basic Information, Manufacturing Base and Competitors
Table 36. Ajanta Pharma Ltd. Major Business
Table 37. Ajanta Pharma Ltd. Tadalafil Oral Product and Services
Table 38. Ajanta Pharma Ltd. Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. Dr. Reddys Laboratories Major Business
Table 41. Dr. Reddys Laboratories Tadalafil Oral Product and Services
Table 42. Dr. Reddys Laboratories Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Qilu Pharmaceutical Major Business
Table 45. Qilu Pharmaceutical Tadalafil Oral Product and Services
Table 46. Qilu Pharmaceutical Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Lupin Basic Information, Manufacturing Base and Competitors
Table 48. Lupin Major Business
Table 49. Lupin Tadalafil Oral Product and Services
Table 50. Lupin Tadalafil Oral Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Tadalafil Oral Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 52. Global Tadalafil Oral Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Tadalafil Oral, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Tadalafil Oral Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Tadalafil Oral Production Site of Key Manufacturer
Table 56. Tadalafil Oral New Entrant and Capacity Expansion Plans
Table 57. Tadalafil Oral Mergers & Acquisitions in the Past Five Years
Table 58. Global Tadalafil Oral Sales by Region (2017-2022) & (K Units)
Table 59. Global Tadalafil Oral Sales by Region (2023-2028) & (K Units)
Table 60. Global Tadalafil Oral Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Tadalafil Oral Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Tadalafil Oral Sales by Type (2017-2022) & (K Units)
Table 63. Global Tadalafil Oral Sales by Type (2023-2028) & (K Units)
Table 64. Global Tadalafil Oral Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Tadalafil Oral Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Tadalafil Oral Price by Type (2017-2022) & (USD/Unit)
Table 67. Global Tadalafil Oral Price by Type (2023-2028) & (USD/Unit)
Table 68. Global Tadalafil Oral Sales by Application (2017-2022) & (K Units)
Table 69. Global Tadalafil Oral Sales by Application (2023-2028) & (K Units)
Table 70. Global Tadalafil Oral Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Tadalafil Oral Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Tadalafil Oral Price by Application (2017-2022) & (USD/Unit)
Table 73. Global Tadalafil Oral Price by Application (2023-2028) & (USD/Unit)
Table 74. North America Tadalafil Oral Sales by Country (2017-2022) & (K Units)
Table 75. North America Tadalafil Oral Sales by Country (2023-2028) & (K Units)
Table 76. North America Tadalafil Oral Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Tadalafil Oral Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Tadalafil Oral Sales by Type (2017-2022) & (K Units)
Table 79. North America Tadalafil Oral Sales by Type (2023-2028) & (K Units)
Table 80. North America Tadalafil Oral Sales by Application (2017-2022) & (K Units)
Table 81. North America Tadalafil Oral Sales by Application (2023-2028) & (K Units)
Table 82. Europe Tadalafil Oral Sales by Country (2017-2022) & (K Units)
Table 83. Europe Tadalafil Oral Sales by Country (2023-2028) & (K Units)
Table 84. Europe Tadalafil Oral Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Tadalafil Oral Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Tadalafil Oral Sales by Type (2017-2022) & (K Units)
Table 87. Europe Tadalafil Oral Sales by Type (2023-2028) & (K Units)
Table 88. Europe Tadalafil Oral Sales by Application (2017-2022) & (K Units)
Table 89. Europe Tadalafil Oral Sales by Application (2023-2028) & (K Units)
Table 90. Asia-Pacific Tadalafil Oral Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Tadalafil Oral Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Tadalafil Oral Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Tadalafil Oral Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Tadalafil Oral Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Tadalafil Oral Sales by Type (2023-2028) & (K Units)
Table 96. Asia-Pacific Tadalafil Oral Sales by Application (2017-2022) & (K Units)
Table 97. Asia-Pacific Tadalafil Oral Sales by Application (2023-2028) & (K Units)
Table 98. South America Tadalafil Oral Sales by Country (2017-2022) & (K Units)
Table 99. South America Tadalafil Oral Sales by Country (2023-2028) & (K Units)
Table 100. South America Tadalafil Oral Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Tadalafil Oral Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Tadalafil Oral Sales by Type (2017-2022) & (K Units)
Table 103. South America Tadalafil Oral Sales by Type (2023-2028) & (K Units)
Table 104. South America Tadalafil Oral Sales by Application (2017-2022) & (K Units)
Table 105. South America Tadalafil Oral Sales by Application (2023-2028) & (K Units)
Table 106. Middle East & Africa Tadalafil Oral Sales by Region (2017-2022) & (K Units)
Table 107. Middle East & Africa Tadalafil Oral Sales by Region (2023-2028) & (K Units)
Table 108. Middle East & Africa Tadalafil Oral Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Tadalafil Oral Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Tadalafil Oral Sales by Type (2017-2022) & (K Units)
Table 111. Middle East & Africa Tadalafil Oral Sales by Type (2023-2028) & (K Units)
Table 112. Middle East & Africa Tadalafil Oral Sales by Application (2017-2022) & (K Units)
Table 113. Middle East & Africa Tadalafil Oral Sales by Application (2023-2028) & (K Units)
Table 114. Tadalafil Oral Raw Material
Table 115. Key Manufacturers of Tadalafil Oral Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Tadalafil Oral Typical Distributors
Table 119. Tadalafil Oral Typical Customers
List of Figures
Figure 1. Tadalafil Oral Picture
Figure 2. Global Tadalafil Oral Revenue Market Share by Type in 2021
Figure 3. 2.5 mg tablets
Figure 4. 5 mg tablets
Figure 5. 10mg tablets
Figure 6. 20 mg tablets
Figure 7. Global Tadalafil Oral Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Drug store
Figure 10. Global Tadalafil Oral Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Tadalafil Oral Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Tadalafil Oral Sales (2017-2028) & (K Units)
Figure 13. Global Tadalafil Oral Price (2017-2028) & (USD/Unit)
Figure 14. Global Tadalafil Oral Production Capacity (2017-2028) & (K Units)
Figure 15. Global Tadalafil Oral Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Tadalafil Oral Market Drivers
Figure 17. Tadalafil Oral Market Restraints
Figure 18. Tadalafil Oral Market Trends
Figure 19. Global Tadalafil Oral Sales Market Share by Manufacturer in 2021
Figure 20. Global Tadalafil Oral Revenue Market Share by Manufacturer in 2021
Figure 21. Tadalafil Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Tadalafil Oral Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Tadalafil Oral Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Tadalafil Oral Sales Market Share by Region (2017-2028)
Figure 25. Global Tadalafil Oral Revenue Market Share by Region (2017-2028)
Figure 26. North America Tadalafil Oral Revenue (2017-2028) & (USD Million)
Figure 27. Europe Tadalafil Oral Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Tadalafil Oral Revenue (2017-2028) & (USD Million)
Figure 29. South America Tadalafil Oral Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Tadalafil Oral Revenue (2017-2028) & (USD Million)
Figure 31. Global Tadalafil Oral Sales Market Share by Type (2017-2028)
Figure 32. Global Tadalafil Oral Revenue Market Share by Type (2017-2028)
Figure 33. Global Tadalafil Oral Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Tadalafil Oral Sales Market Share by Application (2017-2028)
Figure 35. Global Tadalafil Oral Revenue Market Share by Application (2017-2028)
Figure 36. Global Tadalafil Oral Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Tadalafil Oral Sales Market Share by Type (2017-2028)
Figure 38. North America Tadalafil Oral Sales Market Share by Application (2017-2028)
Figure 39. North America Tadalafil Oral Sales Market Share by Country (2017-2028)
Figure 40. North America Tadalafil Oral Revenue Market Share by Country (2017-2028)
Figure 41. United States Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Tadalafil Oral Sales Market Share by Type (2017-2028)
Figure 45. Europe Tadalafil Oral Sales Market Share by Application (2017-2028)
Figure 46. Europe Tadalafil Oral Sales Market Share by Country (2017-2028)
Figure 47. Europe Tadalafil Oral Revenue Market Share by Country (2017-2028)
Figure 48. Germany Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Tadalafil Oral Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Tadalafil Oral Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Tadalafil Oral Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Tadalafil Oral Revenue Market Share by Region (2017-2028)
Figure 57. China Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Tadalafil Oral Sales Market Share by Type (2017-2028)
Figure 64. South America Tadalafil Oral Sales Market Share by Application (2017-2028)
Figure 65. South America Tadalafil Oral Sales Market Share by Country (2017-2028)
Figure 66. South America Tadalafil Oral Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Tadalafil Oral Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Tadalafil Oral Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Tadalafil Oral Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Tadalafil Oral Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Tadalafil Oral Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Tadalafil Oral in 2021
Figure 78. Manufacturing Process Analysis of Tadalafil Oral
Figure 79. Tadalafil Oral Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のタダラフィルAPI市場2022年：市場規模予測（～2028年）
  • タダラフィルAPIのグローバル市場展望 2023年-2029年：99%以上、99%以下
  • 世界のメトトレキサート（MTX）内用液市場2022年：市場規模予測（～2028年）
  • 世界の経口用ジドロゲステロン市場2022年：市場規模予測（～2028年）
  • 世界のメルカプトプリン内服薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19652 )"世界の経口型タダラフィル市場2022年：市場規模予測（～2028年）" (英文：Global Tadalafil Oral Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。